Literature DB >> 28102152

Solanezumab: too late in mild Alzheimer's disease?

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28102152     DOI： 10.1016/S1474-4422(16)30395-7

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  20 in total

1.  Compound AD16 Reduces Amyloid Plaque Deposition and Modifies Microglia in a Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Ping Sun; Hu Yue; Qi Xing; Wenmin Deng; Yitao Ou; Guangjin Pan; Xiaofen Zhong; Wenhui Hu
Journal:  ACS Pharmacol Transl Sci       Date:  2020-11-18

2.  Statin Use and Risk of Cognitive Decline in the ADNI Cohort.

Authors:  Emily C Kemp; Megan K Ebner; Srinath Ramanan; Tyler A Godek; Erika A Pugh; Hugh H Bartlett; Julia W McDonald; Marcia C Mecca; Christopher H van Dyck; Adam P Mecca
Journal:  Am J Geriatr Psychiatry       Date:  2019-11-11       Impact factor: 4.105

Review 3.  Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.

Authors:  Jinsha Liu; Joey Paolo Ting; Shams Al-Azzam; Yun Ding; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

4.  Computational Analysis for the Rational Design of Anti-Amyloid Beta (Aβ) Antibodies.

Authors:  D'Artagnan Greene; Theodora Po; Jennifer Pan; Tanya Tabibian; Ray Luo
Journal:  J Phys Chem B       Date:  2018-04-16       Impact factor: 2.991

Review 5.  EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer's disease.

Authors:  Leon M Tai; Deebika Balu; Evangelina Avila-Munoz; Laila Abdullah; Riya Thomas; Nicole Collins; Ana Carolina Valencia-Olvera; Mary Jo LaDu
Journal:  J Lipid Res       Date:  2017-04-07       Impact factor: 5.922

Review 6.  Alzheimer's disease hypothesis and related therapies.

Authors:  Xiaoguang Du; Xinyi Wang; Meiyu Geng
Journal:  Transl Neurodegener       Date:  2018-01-30       Impact factor: 8.014

Review 7.  Genetic rodent models of brain disorders: Perspectives on experimental approaches and therapeutic strategies.

Authors:  Christopher M McGraw; Christopher S Ward; Rodney C Samaco
Journal:  Am J Med Genet C Semin Med Genet       Date:  2017-09       Impact factor: 3.908

Review 8.  Dual-therapy strategy for modification of adiponectin receptor signaling in aging-associated chronic diseases.

Authors:  Masaaki Waragai; Gilbert Ho; Yoshiki Takamatsu; Yuka Shimizu; Hiromu Sugino; Shuei Sugama; Takato Takenouchi; Eliezer Masliah; Makoto Hashimoto
Journal:  Drug Discov Today       Date:  2018-05-07       Impact factor: 7.851

Review 9.  Anti-Amyloid-β Monoclonal Antibodies for Alzheimer's Disease: Pitfalls and Promise.

Authors:  Christopher H van Dyck
Journal:  Biol Psychiatry       Date:  2017-08-24       Impact factor: 13.382

10.  The development of a stochastic mathematical model of Alzheimer's disease to help improve the design of clinical trials of potential treatments.

Authors:  Christoforos Hadjichrysanthou; Alison K Ower; Frank de Wolf; Roy M Anderson
Journal:  PLoS One       Date:  2018-01-29       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.